Motus GI Holdings, Inc.

MOTS Healthcare Medical Devices

Motus GI Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $319,000.00, down 46.1% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$420.0K
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
2/9
Altman Z
−34.74
Beneish M
n/a
Dividend safety
n/a
Older periods Jun '23 Sep '23 Dec '23 Mar '24
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
9.11 12.57 3.30 11.59
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(1.97) (2.33) (0.57) (1.87)
P/B ratio
0.00 0.00 0.39 1.24
Price to Tangible BV
0.00 0.00 0.39 1.24
EV/Sales
11.43 22.09 (5.12) 3.51
EV/EBITDA
0.00 0.00 0.15 0.00
EV/Operating CF
(0.42) (0.60) 0.15 (0.14)
EV/FCF
(0.42) (0.60) 0.14 (0.13)
Quick Ratio
1.94 1.29 1.54 1.52
Current Ratio
2.20 1.49 1.76 1.74
Net Debt/EBITDA
(0.52) (1.60) 1.20 1.43
Debt/Assets
83.57% 108.20% 31.46% 32.56%
Debt/Equity
(10.19) (3.71) 0.85 0.75
Asset Turnover
0.03 0.03 0.03 0.03
Operating CF/Net income
0.86 0.73 0.66 0.27
Capex/Depreciation
(0.22) (0.07) 0.00 0.00
Interest Coverage
(10.90) (10.78) (45.78) (25.32)
Research and Development Expense of Revenue
671.68% 805.81% 876.56% 710.94%
Selling, General and Administrative Expense of Revenue
1,747.79% 2,022.09% 2,639.06% 2,535.94%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
43.36% 108.14% 167.19% 110.94%
Graham Net Nets
(0.57) (0.92) 1.16 0.46
Graham Number
49.49 56.56 0.00 0.00
Earnings Yield
(566.88%) (491.30%) (2,196.15%) (3,553.86%)
Free Cash Flow Yield
(301.90%) (294.77%) (1,072.93%) (224.79%)
Revenue per Share
0.22 0.14 0.08 0.01
Operating CF per Share
(5.10) (3.14) (2.29) (0.23)
Capex per Share
(0.10) (0.03) 0.00 0.00
Free Cash Flow per Share
(5.20) (3.16) (2.29) (0.23)
Cash per Share
16.91 9.14 6.12 0.57
Shareholders Equity per Share
(1.91) (3.96) 3.32 0.36
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(1.91) (3.96) 3.32 0.36
Free Cash Flow
(2.62) (1.98) (1.86) (2.02)
Working Capital
5.36 2.21 2.49 2.44
Capital Expenditures
(0.05) (0.02) 0.00 —
Net Current Asset Value
(2.89) (4.23) 1.22 1.75
EV/EBIT
0.00 0.00 0.14 0.00
Capex to Sales
0.43 0.19 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
0.09 0.13 0.07 0.07
Average Payables
1.84 2.08 1.91 1.48
Average Inventory
0.74 0.71 0.37 0.35
Average Assets
15.91 12.93 12.44 9.65
Average Common Equity
1.50 (0.86) 2.83 0.99

Fold the line items

Columns are period end dates